ALS drug Albrioza to be voluntarily withdrawn from the market in CanadaPhase 3 PHOENIX trial showed no significant benefit from Albrioza (sodium phenylbutyrate/ursodoxicoltaurine) compared to placebo. Understanding the interplay of menopausal hormone therapy and dementiaFor women under the age of 65 years, especially those under the age of 55 years, there appears to be no increased risk of dementia with MHT. Researchers find a single, surprising gene behind a disorder that causes intellectual disability Those with the condition have a constellation of issues, which also include short stature, small heads, seizures and low muscle mass. This is your brain on belief: How you feel about a drug may influence its effects on your brain Participants’ beliefs about the strength of nicotine they consumed influenced their brain activity, the study showed. QUIZ: Test your knowledge of ALS With recent treatments and cases in the news, how much do you know about this neurodegenerative disorder? NEW PRODUCT: Epidiolex for adjunctive treatment of seizures Get the info you need on this new product, part of our drug news roundup for May. Goodbye spinal tap? A simple blood test to detect Alzheimer’s disease A study shows that a blood test can be as accurate as much more invasive, and expensive, tests in detecting Alzheimer's disease early. Antipsychotics associated with a wide range of adverse outcomes in dementia Risks of a broad range of adverse outcomes need to be considered before prescribing antipsychotic drugs for people with dementia. A mixed bag of supplement studies Vitamins for memory, probiotics for food allergies, magnesium for heart attack patients? Older adults’ brains ‘rewarded’ by music they don’t even like, B.C. researcher finds Sarah Faber said her work on how healthy brains respond to music as they age creates a baseline for future research on people who have Alzheimer’s or dementia to better understand those diseases. First Previous 2 3 4 5 6 Next Last